EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 29 ($0.38) and traded as high as GBX 31 ($0.41). EKF Diagnostics shares last traded at GBX 30.45 ($0.40), with a volume of 27,990 shares.
EKF Diagnostics Stock Down 0.0 %
The firm has a market capitalization of £138.14 million, a price-to-earnings ratio of 3,044.60 and a beta of 0.57. The stock has a fifty day moving average of GBX 28.45 and a two-hundred day moving average of GBX 29.02. The company has a debt-to-equity ratio of 1.78, a current ratio of 4.59 and a quick ratio of 1.77.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- Why is the Ex-Dividend Date Significant to Investors?
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
